Log in to save to my catalogue

Pharmacological inhibition of α-synuclein aggregation within liquid condensates

Pharmacological inhibition of α-synuclein aggregation within liquid condensates

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a17360268c2c42ac8264f7fd9ce9115e

Pharmacological inhibition of α-synuclein aggregation within liquid condensates

About this item

Full title

Pharmacological inhibition of α-synuclein aggregation within liquid condensates

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-05, Vol.15 (1), p.3835-3835, Article 3835

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Aggregated forms of α-synuclein constitute the major component of Lewy bodies, the proteinaceous aggregates characteristic of Parkinson’s disease. Emerging evidence suggests that α-synuclein aggregation may occur within liquid condensates formed through phase separation. This mechanism of aggregation creates new challenges and opportunities for dru...

Alternative Titles

Full title

Pharmacological inhibition of α-synuclein aggregation within liquid condensates

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a17360268c2c42ac8264f7fd9ce9115e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a17360268c2c42ac8264f7fd9ce9115e

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-47585-x

How to access this item